The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,346K data for 622K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

7 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
A versatile photoactivatable probe designed to label the diphosphate binding site of farnesyl diphosphate utilizing enzymes.EBI
University Of Minnesota
Targeting KRAS mutant cancers by preventing signaling transduction in the MAPK pathway.EBI
Massachusetts College Of Pharmacy And Health Sciences University
Discovery of an Anion-Dependent Farnesyltransferase Inhibitor from a Phenotypic Screen.EBI
Merck
Design, synthesis, and biological activity of 4-[(4-cyano-2-arylbenzyloxy)-(3-methyl-3H-imidazol-4-yl)methyl]benzonitriles as potent and selective farnesyltransferase inhibitors.BDB
Globe Pharmaceutical R And Abbott Laboratories
Synthesis, pharmacological evaluation, and molecular modeling studies of novel peptidic CAAX analogues as farnesyl-protein-transferase inhibitors.BDB
Universita Di Napoli Federico Ii
Protein farnesyltransferase inhibitors exhibit potent antimalarial activity.BDB
University Of Washington At Seattle
Structurally simple, potent, Plasmodium selective farnesyltransferase inhibitors that arrest the growth of malaria parasites.BDB
Yale University